PB2032: MAGNETISMM-9: AN OPEN-LABEL, MULTICENTER, NON-RANDOMIZED PHASE 1/2 STUDY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
oleh: R. Fonseca, J. Kuroda, T. Ishida, R. Popat, J. S. Huang, A. Yver, E. Vandendries, M. Elmeliegy, W. D. Ma, D. W. Sborov
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2022-06-01 |
Deskripsi
No description available for this item.